ADVOS – ADVANCED ORGAN SUPPORT
The ADVOS procedure from ADVITOS is an innovative system for treating multiple organ failure in intensive care units: the world’s first dialysis treatment for acid-base homeostasis that comprises four organ support therapies.

The new generation ADVOS BK300 offers a unique platform that enables fully integrated extracorporeal blood purification therapies with a treatment duration of up to 72 hours (RRT - renal replacement therapy)..
The ADVOS therapy from ADVITOS is CE certified and patented worldwide. Our vision is to establish effective organ support and acidosis therapies as the standard of care for millions of intensive care patients worldwide.
Current topics
The Next Generation ADVOS BK300
A new era in extracorporeal blood purification

By playing, the YouTube provider may also set cookies and analyse your usage behaviour (tracking).
For more information, including a link to the provider's privacy policy, please see our privacy policy.